cd83 monoclonal antibody product Search Results


cd8  (ATCC)
90
ATCC cd8
Cd8, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd8/product/ATCC
Average 90 stars, based on 1 article reviews
cd8 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti cd83  (Miltenyi Biotec)
95
Miltenyi Biotec anti cd83
Anti Cd83, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd83/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
anti cd83 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
anti-cd83 (ig g1 )  (Becton Dickinson)
90
Becton Dickinson anti-cd83 (ig g1 )
Anti Cd83 (Ig G1 ), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cd83 (ig g1 )/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
anti-cd83 (ig g1 ) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-cd83 hb15a  (Immunotec inc)
90
Immunotec inc anti-cd83 hb15a
Anti Cd83 Hb15a, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cd83 hb15a/product/Immunotec inc
Average 90 stars, based on 1 article reviews
anti-cd83 hb15a - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pe-conjugated mouse anti-human cd83 antibody  (IQ Products)
90
IQ Products pe-conjugated mouse anti-human cd83 antibody
Pe Conjugated Mouse Anti Human Cd83 Antibody, supplied by IQ Products, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe-conjugated mouse anti-human cd83 antibody/product/IQ Products
Average 90 stars, based on 1 article reviews
pe-conjugated mouse anti-human cd83 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-cd83 (hb15e)  (Becton Dickinson)
90
Becton Dickinson anti-cd83 (hb15e)
Anti Cd83 (Hb15e), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cd83 (hb15e)/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
anti-cd83 (hb15e) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd83 pe antibody  (Thermo Fisher)
90
Thermo Fisher cd83 pe antibody
Leukocyte distribution in peripheral blood, lymph nodes and spleen at day 15 after starting DSS exposure. The indicated therapeutics (bLf, sIgA, IgG, and BC) and controls (NaCl and BSA) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. Values are presented as percent positive CD11c + <t>CD83</t> + ( A ) or γδ TCR + ( B ) of 10,000 measured events and given as mean ± SD; n = 12 (Untreated) n = 8 (NaCl), n = 6 (BC, sIgA, IgG), and n = 5 (bLf, BSA). *p < 0.05 vs. Untreated; +p < 0.05 vs. NaCl, Mann Whitney U -test.
Cd83 Pe Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd83 pe antibody/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
cd83 pe antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
fitc-conjugated anti-cd14  (Becton Dickinson)
90
Becton Dickinson fitc-conjugated anti-cd14
Leukocyte distribution in peripheral blood, lymph nodes and spleen at day 15 after starting DSS exposure. The indicated therapeutics (bLf, sIgA, IgG, and BC) and controls (NaCl and BSA) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. Values are presented as percent positive CD11c + <t>CD83</t> + ( A ) or γδ TCR + ( B ) of 10,000 measured events and given as mean ± SD; n = 12 (Untreated) n = 8 (NaCl), n = 6 (BC, sIgA, IgG), and n = 5 (bLf, BSA). *p < 0.05 vs. Untreated; +p < 0.05 vs. NaCl, Mann Whitney U -test.
Fitc Conjugated Anti Cd14, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc-conjugated anti-cd14/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
fitc-conjugated anti-cd14 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pe anti cd83  (Bio-Rad)
93
Bio-Rad pe anti cd83
Leukocyte distribution in peripheral blood, lymph nodes and spleen at day 15 after starting DSS exposure. The indicated therapeutics (bLf, sIgA, IgG, and BC) and controls (NaCl and BSA) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. Values are presented as percent positive CD11c + <t>CD83</t> + ( A ) or γδ TCR + ( B ) of 10,000 measured events and given as mean ± SD; n = 12 (Untreated) n = 8 (NaCl), n = 6 (BC, sIgA, IgG), and n = 5 (bLf, BSA). *p < 0.05 vs. Untreated; +p < 0.05 vs. NaCl, Mann Whitney U -test.
Pe Anti Cd83, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe anti cd83/product/Bio-Rad
Average 93 stars, based on 1 article reviews
pe anti cd83 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
pe-conjugated anti-cd86 (po3.1)  (Thermo Fisher)
90
Thermo Fisher pe-conjugated anti-cd86 (po3.1)
Leukocyte distribution in peripheral blood, lymph nodes and spleen at day 15 after starting DSS exposure. The indicated therapeutics (bLf, sIgA, IgG, and BC) and controls (NaCl and BSA) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. Values are presented as percent positive CD11c + <t>CD83</t> + ( A ) or γδ TCR + ( B ) of 10,000 measured events and given as mean ± SD; n = 12 (Untreated) n = 8 (NaCl), n = 6 (BC, sIgA, IgG), and n = 5 (bLf, BSA). *p < 0.05 vs. Untreated; +p < 0.05 vs. NaCl, Mann Whitney U -test.
Pe Conjugated Anti Cd86 (Po3.1), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe-conjugated anti-cd86 (po3.1)/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
pe-conjugated anti-cd86 (po3.1) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pe-conjugated anti-cd83 hb15e  (Thermo Fisher)
90
Thermo Fisher pe-conjugated anti-cd83 hb15e
Leukocyte distribution in peripheral blood, lymph nodes and spleen at day 15 after starting DSS exposure. The indicated therapeutics (bLf, sIgA, IgG, and BC) and controls (NaCl and BSA) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. Values are presented as percent positive CD11c + <t>CD83</t> + ( A ) or γδ TCR + ( B ) of 10,000 measured events and given as mean ± SD; n = 12 (Untreated) n = 8 (NaCl), n = 6 (BC, sIgA, IgG), and n = 5 (bLf, BSA). *p < 0.05 vs. Untreated; +p < 0.05 vs. NaCl, Mann Whitney U -test.
Pe Conjugated Anti Cd83 Hb15e, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe-conjugated anti-cd83 hb15e/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
pe-conjugated anti-cd83 hb15e - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd83 (michel-19)  (Thermo Fisher)
90
Thermo Fisher cd83 (michel-19)
Leukocyte distribution in peripheral blood, lymph nodes and spleen at day 15 after starting DSS exposure. The indicated therapeutics (bLf, sIgA, IgG, and BC) and controls (NaCl and BSA) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. Values are presented as percent positive CD11c + <t>CD83</t> + ( A ) or γδ TCR + ( B ) of 10,000 measured events and given as mean ± SD; n = 12 (Untreated) n = 8 (NaCl), n = 6 (BC, sIgA, IgG), and n = 5 (bLf, BSA). *p < 0.05 vs. Untreated; +p < 0.05 vs. NaCl, Mann Whitney U -test.
Cd83 (Michel 19), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd83 (michel-19)/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
cd83 (michel-19) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Leukocyte distribution in peripheral blood, lymph nodes and spleen at day 15 after starting DSS exposure. The indicated therapeutics (bLf, sIgA, IgG, and BC) and controls (NaCl and BSA) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. Values are presented as percent positive CD11c + CD83 + ( A ) or γδ TCR + ( B ) of 10,000 measured events and given as mean ± SD; n = 12 (Untreated) n = 8 (NaCl), n = 6 (BC, sIgA, IgG), and n = 5 (bLf, BSA). *p < 0.05 vs. Untreated; +p < 0.05 vs. NaCl, Mann Whitney U -test.

Journal: BMC Immunology

Article Title: Alteration of DSS-mediated immune cell redistribution in murine colitis by oral colostral immunoglobulin

doi: 10.1186/1471-2172-14-10

Figure Lengend Snippet: Leukocyte distribution in peripheral blood, lymph nodes and spleen at day 15 after starting DSS exposure. The indicated therapeutics (bLf, sIgA, IgG, and BC) and controls (NaCl and BSA) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. Values are presented as percent positive CD11c + CD83 + ( A ) or γδ TCR + ( B ) of 10,000 measured events and given as mean ± SD; n = 12 (Untreated) n = 8 (NaCl), n = 6 (BC, sIgA, IgG), and n = 5 (bLf, BSA). *p < 0.05 vs. Untreated; +p < 0.05 vs. NaCl, Mann Whitney U -test.

Article Snippet: Briefly, leukocytes were labeled using the following fluorescein isothiocyanate (FITC)- and phycoerythrin (PE)-conjugated anti-mouse monoclonal antibodies (mAbs) at the appropriate concentrations: CD3ε FITC, CD19 FITC, γδ TCR PE (ImmunoTools, Fiesoythe, Germany), CD11b FITC, CD11c FITC, CD4 PE, CD8 PE; Gr-1 PE (Miltenyi Biotech, Bergisch-Gladbach, Germany), CD83 PE (eBioscience, Frankfurt, Germany).

Techniques: MANN-WHITNEY

Colonic infiltration of prophylactically-fed, DSS-exposed mice and untreated control without intervention at day 15. The indicated therapeutics (sIgA, IgG, and BC) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. A : Immunohistochemical staining of a ) CD11c + mature dendritic cells or b ) γδTCR + T-cells in the colon of DSS-exposed mice compared to untreated, healthy controls. Representative images are shown in 200-fold magnification. B : Impact of prophylactic sIgA on cell distribution in lymph nodes and spleen at day 15. The indicated therapeutics (sIgA, IgG, and BC) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. Values are given as percent CD3 + CD4 + (A), γδTCR + (B), or CD11c + CD83 + (C) positive cells of 10,000 measured events and given as mean ± SD. n = 6-8 (Untreated), n = 6 (BC, sIgA), and n = 5 (IgG) mice. * P < 0.05 vs. untreated, Mann Whitney U -test.Values are means ± SD of n = 6 (Untreated, BC, IgA) and n = 5 (IgG) mice.* P < 0.01 vs. untreated, + P < 0.05 vs. IgG, Mann Whitney U -test.

Journal: BMC Immunology

Article Title: Alteration of DSS-mediated immune cell redistribution in murine colitis by oral colostral immunoglobulin

doi: 10.1186/1471-2172-14-10

Figure Lengend Snippet: Colonic infiltration of prophylactically-fed, DSS-exposed mice and untreated control without intervention at day 15. The indicated therapeutics (sIgA, IgG, and BC) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. A : Immunohistochemical staining of a ) CD11c + mature dendritic cells or b ) γδTCR + T-cells in the colon of DSS-exposed mice compared to untreated, healthy controls. Representative images are shown in 200-fold magnification. B : Impact of prophylactic sIgA on cell distribution in lymph nodes and spleen at day 15. The indicated therapeutics (sIgA, IgG, and BC) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. Values are given as percent CD3 + CD4 + (A), γδTCR + (B), or CD11c + CD83 + (C) positive cells of 10,000 measured events and given as mean ± SD. n = 6-8 (Untreated), n = 6 (BC, sIgA), and n = 5 (IgG) mice. * P < 0.05 vs. untreated, Mann Whitney U -test.Values are means ± SD of n = 6 (Untreated, BC, IgA) and n = 5 (IgG) mice.* P < 0.01 vs. untreated, + P < 0.05 vs. IgG, Mann Whitney U -test.

Article Snippet: Briefly, leukocytes were labeled using the following fluorescein isothiocyanate (FITC)- and phycoerythrin (PE)-conjugated anti-mouse monoclonal antibodies (mAbs) at the appropriate concentrations: CD3ε FITC, CD19 FITC, γδ TCR PE (ImmunoTools, Fiesoythe, Germany), CD11b FITC, CD11c FITC, CD4 PE, CD8 PE; Gr-1 PE (Miltenyi Biotech, Bergisch-Gladbach, Germany), CD83 PE (eBioscience, Frankfurt, Germany).

Techniques: Control, Immunohistochemical staining, Staining, MANN-WHITNEY

Impact of prophylactic sIgA on cell distribution in lymph nodes and spleen at day 15. The indicated therapeutics (sIgA, IgG, and BC) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. Values are given as percent CD3 + CD4 + ( A ), γδTCR + ( B ), or CD11c + CD83 + ( C ) positive cells of 10,000 measured events and given as mean ± SD. n=6-8 (Untreated), n=6 (BC, sIgA), and n=5 (IgG) mice. * P <0.05 vs. untreated, Mann Whitney U -test.

Journal: BMC Immunology

Article Title: Alteration of DSS-mediated immune cell redistribution in murine colitis by oral colostral immunoglobulin

doi: 10.1186/1471-2172-14-10

Figure Lengend Snippet: Impact of prophylactic sIgA on cell distribution in lymph nodes and spleen at day 15. The indicated therapeutics (sIgA, IgG, and BC) were applied parallel to DSS treatment. The untreated group represents healthy animals without any intervention. Values are given as percent CD3 + CD4 + ( A ), γδTCR + ( B ), or CD11c + CD83 + ( C ) positive cells of 10,000 measured events and given as mean ± SD. n=6-8 (Untreated), n=6 (BC, sIgA), and n=5 (IgG) mice. * P <0.05 vs. untreated, Mann Whitney U -test.

Article Snippet: Briefly, leukocytes were labeled using the following fluorescein isothiocyanate (FITC)- and phycoerythrin (PE)-conjugated anti-mouse monoclonal antibodies (mAbs) at the appropriate concentrations: CD3ε FITC, CD19 FITC, γδ TCR PE (ImmunoTools, Fiesoythe, Germany), CD11b FITC, CD11c FITC, CD4 PE, CD8 PE; Gr-1 PE (Miltenyi Biotech, Bergisch-Gladbach, Germany), CD83 PE (eBioscience, Frankfurt, Germany).

Techniques: MANN-WHITNEY